Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-06-23
1988-01-05
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514807, 530315, H61K 3734, C07K 716
Patent
active
047177152
ABSTRACT:
Vasopressin antagonists which have a dipeptide side chain comprised of two basic amino acids demonstrate potent V.sub.1 and V.sub.2 -antagonist activity. A species of the invention, which is prepared by conventional peptide sequencing, is [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylene propionic acid)-2-(O-ethyl)-D-tyrosine-4-valine-7-arginine-8-arginine-9-desglycine]- vasopressin.
REFERENCES:
patent: 4469679 (1984-09-01), Huffman et al.
patent: 4481193 (1984-11-01), Ali et al.
patent: 4481194 (1984-11-01), Ali et al.
M. Manning et al., Nature, 308 652 (1984).
Lourie Alan D.
Phillips Delbert R.
SmithKline Beckman Corporation
Suter Stuart R.
Williams Janice E.
LandOfFree
ARG.sup.7 -ARG.sup.8 -vasopressin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ARG.sup.7 -ARG.sup.8 -vasopressin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ARG.sup.7 -ARG.sup.8 -vasopressin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-9226